C. Robert Horsburgh Jr, MD
Professor of Epidemiology
Boston University School of Public Health
Dept of Epidemiology

MD, Case Western Reserve University
MS, Yale University




Dr. Horsburgh has 30 years of experience in public health and medicine. He currently holds faculty positions in the Department of Biostatistics, the Department of GLobal Health and the Department of Medicine. Dr. Horsburgh teaches courses in the Epidemiology of AIDS and the Epidemiology of Tuberculosis. His research focuses on tuberculosis, nontuberculous mycobacterial infections and opportunistic infections in AIDS. Currently, he is involved in research in Brazil, India, Peru, South Africa and Tanzania. He has served as the National Steering Committee Co-Chairman of the Tuberculosis Trials Consortium and the Tuberculosis Epidemiologic Studies Consortium. He is currently the Chairman of the Steering Committee of RESIST-TB, an international organization dedicated to improving MDR-TB treatment through Clinical Trials (www.resisttb.org). His office is located in the Center for Global Health and Development at BU School of Public Health.

Professor
Boston University School of Public Health
Global Health


Professor
Boston University School of Medicine
Medicine
Infectious Diseases

Professor
Boston University School of Public Health
Biostatistics


Boston Medical Center



2015 International Union Against Tuberculosis and Lung Disease, North American Region: Lifetime Achievement Award
2011 Boston University School of Public Health: Faculty Career Award in Research and Scholarship
2011 CDC: Excellence in Public Health Impact Award
2004 BUSPH: Teaching Award
1997 Emory University: Teaching Award
1989 US PHS Commendation Medal
1977 Lubrizol Award for Patient Care


Providence/Boston Center for AIDS Research (CFAR): Core Support (Cores A, B, E, G, K, SWG)
07/01/2018 - 06/30/2023 (PI)
The Miriam Hospital NIH NIAID
2P30AI042853-20A1

Dartmouth-Boston University HIV-TB Research Training for the Infectious Disease Institute at Muhimbili University of Health and Allied Sciences
06/01/2018 - 05/31/2023 (PI)
Dartmouth College NIH FIC
2D43TW009573-06

Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT)
08/15/2017 - 07/31/2022 (PI)
NIH/National Institute of Allergy & Infectious Diseases
5R01AI134430-02

Tuberculosis Trials Consortium
10/01/2014 - 09/30/2019 (PI)
Veterans Affairs Medical Center of Washington DC HHS CDC


Phase 2 Pharmacodynamic Study of High-dose Levofloxacin inMDR-TB Treatment
08/01/2016 - 07/31/2019 (PI)
NIH/National Institute of Allergy & Infectious Diseases
4U01AI100805-04

The impact of Alcohol Consumption on TB Treatment Outcomes
04/08/2016 - 03/31/2019 (PI)
Boston Medical Center Corporation NIH NIAID
5R01AI119037-03

Impact of Pregnancy on Tuberculosis
08/25/2015 - 10/31/2018 (PI)
Boston Medical Center Corporation NIH NIAID
5R01AI124217-04

Biomarkers and mechanisms of Paucibacillary and Latent Tuberculosis
08/01/2014 - 10/31/2018 (PI)
Boston Medical Center Corporation NIH NIAID
5U19AI111276-05

Biomarkers for Risk of TB and for TB Treatment Failure and Relapse
10/02/2013 - 09/30/2018 (PI)
Boston Medical Center Corporation National Science Fdn
OISE-9531011

Lifespan/Tufts/brown Center for AIDS Research (CFAR): Core A, Core B, Core G and SWG1
07/01/2016 - 06/30/2018 (PI)
The Miriam Hospital NIH NIAID
3P30AI042853-19S1

Showing 10 of 26 results. Show All Results

BU Clinical HIV/AIDS Research Training Program
08/01/2016 - 07/31/2021 (PI)
NIH-NIAID
5T32AI052074-13

Lifespan/Tufts/brown Center for AIDS Research (CFAR): Core K Clinical Sciences Core
07/01/2016 - 06/30/2019 (PI)
Miriam Hospital NIH-NIAID

MDR-TB and HIV at RePORT Sites in India (Supplement)
08/24/2017 - 08/23/2018 (PI)
U.S. Civilian Research and Development Foundation National Science Fdn

BU Clinical HIV/AIDS Research Training Program
08/02/2010 - 07/31/2016 (PI)
NIH-NIAID
5T32AI052074-10

Boston Community Partnership Against HIV
09/30/2002 - 09/29/2005 (PI)
DHHS-Office Minority Hlth

History Of Hepatitis C Infecti
09/30/1999 - 06/30/2005 (PI)
NIH-NIDDK
5 R01 DK56410-05 & Supplement



Yr Title Project-Sub Proj Pubs
2018 Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT) 5R01AI134430-02
2018 BU Clinical HIV/AIDS Research Training Program 5T32AI052074-13 39
2018 Clinical Core 5U19AI111276-05-7772 25
2017 Predictors of Resistance Emergence Evaluation in MDR-TB Patients on Treatment (PREEMPT) 1R01AI134430-01
2017 BU Clinical HIV/AIDS Research Training Program 5T32AI052074-12 39
2017 Clinical Core 5U19AI111276-04-7772 25
2017 Biomarkers of Persistent TB Infection and TB Treatment Relapse 5U19AI111276-04-7767 25
2016 Phase 2 Pharmacodynamic Study of High-dose Levofloxacin in MDR-TB Treatment 4U01AI100805-04 3
2016 BU Clinical HIV/AIDS Research Training Program 2T32AI052074-11A1 39
2016 Biomarkers of Persistent TB Infection and TB Treatment Relapse 5U19AI111276-03-7767 25
Showing 10 of 46 results. Show All Results
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Martinez L, Lo NC, Cords O, Hill PC, Khan P, Hatherill M, Mandalakas A, Kay A, Croda J, Horsburgh CR, Zar HJ, Andrews JR. Paediatric tuberculosis transmission outside the household: challenging historical paradigms to inform future public health strategies. Lancet Respir Med. 2019 Jun; 7(6):544-552. PMID: 31078497.
     
  2. Martinez L, Verma R, Croda J, Horsburgh CR, Walter KS, Degner N, Middelkoop K, Koch A, Hermans S, Warner D, Wood R, Cobelens F, Andrews JR. Detection, survival and infectious potential of Mycobacterium tuberculosis in the environment: A review of the evidence and epidemiological implications. Eur Respir J. 2019 May 02. PMID: 31048345.
     
  3. Sinha P, Davis J, Saag L, Wanke C, Salgame P, Mesick J, Horsburgh CR, Hochberg NS. Undernutrition and Tuberculosis: Public Health Implications. J Infect Dis. 2019 Apr 16; 219(9):1356-1363.View Related Profiles. PMID: 30476125.
     
  4. Hoyt KJ, Sarkar S, White L, Joseph NM, Salgame P, Lakshminarayanan S, Muthaiah M, Vinod Kumar S, Ellner JJ, Roy G, Horsburgh CR, Hochberg NS. Effect of malnutrition on radiographic findings and mycobacterial burden in pulmonary tuberculosis. PLoS One. 2019; 14(3):e0214011.View Related Profiles. PMID: 30917170.
     
  5. Berhanu RH, Schnippel K, Kularatne R, Firnhaber C, Jacobson KR, Horsburgh CR, Lippincott CK. Discordant rifampicin susceptibility results are associated with Xpert® MTB/RIF probe B and probe binding delay. Int J Tuberc Lung Dis. 2019 Mar 01; 23(3):358-362.View Related Profiles. PMID: 30940300.
     
  6. Chiang SS, Sheremeta Y, Padilla RS, Jenkins HE, Horsburgh CR, Petrenko V, Rybak NR. Pediatric Multidrug-resistant Tuberculosis in Kyiv City, Ukraine. J Epidemiol Glob Health. 2019 Mar; 9(1):56-61.View Related Profiles. PMID: 30932391.
     
  7. Freiman JM, Wang J, Easterbrook PJ, Horsburgh CR, Marinucci F, White LF, Kamkamidze G, Krajden M, Loarec A, Njouom R, Nguyen KV, Shiha G, Soliman R, Solomon SS, Tsertsvadze T, Denkinger CM, Linas B. Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset. J Hepatol. 2019 Jul; 71(1):62-70.View Related Profiles. PMID: 30797050.
     
  8. Reddy KP, Gupta-Wright A, Fielding KL, Costantini S, Zheng A, Corbett EL, Yu L, van Oosterhout JJ, Resch SC, Wilson DP, Horsburgh CR, Wood R, Alufandika-Moyo M, Peters JA, Freedberg KA, Lawn SD, Walensky RP. Cost-effectiveness of urine-based tuberculosis screening in hospitalised patients with HIV in Africa: a microsimulation modelling study. Lancet Glob Health. 2019 Feb; 7(2):e200-e208. PMID: 30683239.
     
  9. Yuengling KA, Padayatchi N, Wolf A, Mathema B, Brown T, Horsburgh CR, O'Donnell MR. Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug-Resistant Tuberculosis (XDR-TB) HIV Coinfection Treatment in KwaZulu-Natal, South Africa. J Acquir Immune Defic Syndr. 2018 Dec 01; 79(4):474-480. PMID: 30212394.
     
  10. Lambert LA, Katz D, Feng PJ, Djojonegoro BM, Fair E, Jasuja S, Marantz S, Horsburgh CR, Ho C. Impact of Choice of Test for Latent Tuberculosis Infection on Treatment Acceptance and Completion. Microbiol Insights. 2018; 11:1178636118811311. PMID: 30505150; DOI: 10.1177/1178636118811311;.
     
Showing 10 of 268 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 268 publications over 38 distinct years, with a maximum of 19 publications in 2018

YearPublications
19811
19833
19844
19855
19865
19875
19884
198914
19904
19916
19928
19939
19947
19958
19965
19978
19985
19997
20008
20012
20025
20034
20045
20053
20069
20073
20087
20093
201011
201114
20128
201310
20149
201512
201611
20179
201819
20198
Contact for Mentoring:


715 Albany St Talbot Building
Boston MA 02118
Google Map


Horsburgh's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department